1. Home
  2. OBT vs ZURA Comparison

OBT vs ZURA Comparison

Compare OBT & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orange County Bancorp Inc.

OBT

Orange County Bancorp Inc.

HOLD

Current Price

$37.98

Market Cap

457.5M

Sector

Finance

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.36

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBT
ZURA
Founded
1892
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
457.5M
455.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
OBT
ZURA
Price
$37.98
$5.36
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
$36.00
$13.00
AVG Volume (30 Days)
33.7K
1.6M
Earning Date
04-28-2026
05-14-2026
Dividend Yield
2.12%
N/A
EPS Growth
34.82
N/A
EPS
1.87
N/A
Revenue
N/A
N/A
Revenue This Year
$14.27
N/A
Revenue Next Year
$7.99
N/A
P/E Ratio
$20.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.25
$1.88
52 Week High
$40.10
$7.25

Technical Indicators

Market Signals
Indicator
OBT
ZURA
Relative Strength Index (RSI) 52.07 44.02
Support Level $36.22 $5.22
Resistance Level $38.53 $5.87
Average True Range (ATR) 1.22 0.43
MACD -0.02 -0.05
Stochastic Oscillator 82.87 3.54

Price Performance

Historical Comparison
OBT
ZURA

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: